Cynosure Lutronic's XERF™, the world's first multifrequency monopolar RF device for non-invasive structural skin tightening, has surpassed 2,000 installed units worldwide in less than two years since its launch in Korea in May 2024. The second 1,000 installations were achieved three times faster than the first, driven by strong demand in Asia-Pacific and North America. This rapid scaling signals growing confidence among medical aesthetic clinics and consumers, making XERF a key device for distributors and clinics looking to lead in the skin tightening category.
Market signal
XERF has more than tripled its adoption pace in recent months, with Asia-Pacific and North America leading the surge. In the United States, it has consistently led Google search interest among monopolar RF devices, indicating rapidly growing consumer awareness and demand for advanced, non-invasive skin tightening treatments with no downtime. Across Asia-Pacific, XERF has built a visible presence in Korea, Hong Kong SAR, Thailand, Vietnam, Singapore, the Philippines, and Australia, supported by branded out-of-home activations and clinic-level engagement.
Technology highlights
XERF is a dual-frequency monopolar RF system combining 6.78 MHz and 2 MHz to deliver controlled energy to multiple depths, selectively heating fibrous septa for structural skin tightening. Enhanced by Wave Fit™ pulse technology, integrated cooling, and real-time temperature monitoring, it provides precise, effective, and safe treatments without needles or numbing. The system enables three-level depth control with ten energy levels, allowing practitioners to target shallow, mid, and deep tissue in a single session. Its patented Spider Pattern Effector ensures uniform RF energy distribution, reducing edge overheating and improving safety across larger treatment areas.
What buyers should watch
For importers and distributors, XERF's accelerating adoption and strong consumer demand signal a growing market for non-invasive skin tightening devices. The device's dual-frequency technology and proven clinical results make it a competitive option for clinics seeking to differentiate their offerings. With continued investment and rollout into more markets, XERF is positioned to lead the skin tightening category globally. Distributors should monitor regulatory approvals and market entry opportunities in their regions, as well as the potential for branded consumer campaigns to drive clinic traffic.
Sourcing context
Cynosure Lutronic, a global leader in energy-based dermatology and medical aesthetic technologies, has over 100,000 installed systems worldwide and 1,100 employees across North America, EMEA, and APAC. The company's portfolio spans skin tightening, revitalization, resurfacing, hair removal, and vascular procedures. XERF's patents are granted in South Korea (Patent No. 10-2867360) and Japan (Patent No. 7846168), which may affect sourcing and distribution rights in those markets.
Source: Read the original report | Published: June 11, 2026